Clinical trial
Phase II Study of Theophylline in Chronic Lymphocytic Leukemia
NCT00003808 is registered in ClinicalTrials.gov with Eastern Cooperative Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of Theophylline in Chronic Lymphocytic Leukemia
- Lead sponsor
- Eastern Cooperative Oncology Group
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 11, 1999
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- 71
Conditions
As the registry lists them; a condition with its own page is linked.